564 participants
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2023-12-05
- Completion:
- 2027-08-04
Conditions
- ER+ HER2- Advanced Breast Cancer
- High-grade Serous Ovarian Cancer (HGSOC)
Interventions
- DRUG
No Results Yet